Advanced Search


Study ID Status Title Patient Level Data
108344 Completed An open, multicentric, post-marketing surveillance study to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals’ Poliomyelitis vaccine (inactivated) -Poliorix™, administered in Korean children as a primary vaccination in healthy subjects aged two to six months or as a booster vaccination in subjects aged four to six years
108366 Completed An Open-label, Sequential Study to Evaluate the Pharmacokinetics of Simvastatin When Coadministered With Albiglutide in Healthy Adult Subjects Study Listed on
108370 Completed An adaptive design study for the assessment of the pharmacokinetics of albiglutide in subjects with normal renal function and subjects with moderate-to-severe renal impairment and hemodialysis. Study Listed on
108372 Completed A single-site, randomized, double-blind, placebo-controlled, parallel-group, stepped glucose clamp study to assess the effects of albiglutide on counter-regulatory hormone responses and recovery from hypoglycemia in subjects with Type 2 diabetes mellitus. Study Listed on
108392 Relinquished An open-label, multi-centre rollover study to assess the safety and efficacy of eltrombopag in thrombocytopenic subjects with hepatitis C virus (HCV) infection who are otherwise eligible to initiate antiviral therapy (peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin)
108414 Completed A placebo-controlled, single blind, randomized two part study toinvestigate the tolerability, pharmacokinetics, and brainDopamine D3 receptor occupancy of increasing repeat doses ofGSK618334 for up to 21 days in healthy volunteers. Study Listed on
108428 Withdrawn A study to investigate the effects of GSK598809 in newly abstinent nicotine-dependent subjects.
108464 Completed A multicentre study to evaluate the immunogenicity and safety of GSK Biologicals’ HPV vaccine (580299) Co-administered with Boostrix Polio (dTpa-IPV) in healthy female subjects aged 10–18 years Study Listed on
108486 Completed A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes Mellitus Study Listed on
108494 Completed A phase II, single-blind, randomized, controlled, multicentre vaccination study to evaluate the safety and immune response of the GSK Biologicals Zoster vaccine, gE/AS01B, and to compare 3 doses of gE with AS01B adjuvant in healthy elderly subjects, aged 60 to 69 years and 70 years and above. Study Listed on
108504 Completed An open label, single dose, randomised, parallel group pharmacokinetic study to evaluate a combination product containing naproxen sodium and sumatriptan in adolescent subjects with migraine and healthy adult subjects administered at three doses. Study Listed on
108543 Completed Phase I Study of SB751689 - Single and Multiple oral dose study in Japanese postmenopausal women -
108595 Mth18 Relinquished Assess long term persistence of a primary dose of GSK Biologicals' meningococcal vaccine 134612 versus one dose of Mencevax™ ACWY in healthy adolescents/young adults (15 to 19 years at vaccination) Study Listed on
108638 Completed Immunogenicity and safety study of GlaxoSmithKline (GSK) Biologicals’ Boostrix (dTpa) vaccine and the Chinese DT vaccine, when administered as booster vaccination in healthy children aged 6-8 years Study Listed on
108656 Completed A study to evaluate the immunogenicity, safety and reactogenicity of adjuvanted influenza vaccine candidates compared to Fluarix™ administered intramuscularly in subjects aged 18-59 years. Study Listed on
108658 Completed Evaluate Non-Inferiority and Persistence of the Immune Response of GSK Biologicals' Meningococcal Vaccine 134612 Versus Meningitec™ or Mencevax™ ACWY in Healthy Subjects (1-10 Years of Age) Study Listed on
108701 Terminated A randomized, open label, multicentre study to compare the pharmaco-economic implications of an analgesia based regimen with remifentanil and a conventional sedation based regimen using propofol in medical and post-surgical ICU subjects requiring mechanical ventilation for at least 2 days.
108706 Completed A dose-ranging study to compare the safety and immunogenicity of a candidate Human deficiency virus (HIV) vaccine 732461, adjuvanted or not, administered according to a 0, 1 month schedule to healthy adult HIV seronegative volunteers.
108708 Completed A study to evaluate the immunogenicity, safety and reactogenicity of a second vaccination with the adjuvanted influenza vaccine candidate compared to Fluarix™ administered intramuscularly in elderly aged 60 years and above. Study Listed on
108745 Completed Systematische Dokumentation von Patienten mit akutem HIT-Verdacht
108760 Completed Immunogenicity & safety study of GSK Biologicals’ 208136 vaccine formulated with new measles and rubella working seeds Study Listed on
108835 Completed An Open Label, Multicentre Study to Evaluate Patient Satisfaction with Fluticasone/Salmeterol HFA MDI with Counter in Adult Subjects (18 years of age and older) with Asthma or COPD.
108844 Relinquished Study VEG108844, A study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
108862 Completed Post-Marketing Clinical Study of REQUIP (Ropinirole Hydrochloride) Tablets in Patients with Parkinson's Disease- Evaluation of Long-Term Efficacy and Safety -
108888 Completed FondaparinUx Trial with Unfractionated Heparin (UFH) during Revascularization in Acute Coronary Syndromes (ACS) (FUTURA). A prospective study evaluating the safety of two regimens of adjunctive intravenous UFH during PCI in high risk patients with Unstable Angina/Non ST segment elevation myocardial infarction (UA/NSTEMI) initially treated with subcutaneous fondaparinux and referred for early coronary angiography (OASIS 8) Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.